2019 Cannabis Business Award's Publication of the Year |
WEDNESDAY, SEPTEMBER 13, 2023 |
FMCPG HAS BEEN SERVING THE PHYSICAN COMMUNITY
SINCE 2020 |
REGISTER FOR TONIGHT'S MEETING WEDNESDAY, SEPTEMBER 20, 2023 AT 6:30PM THE "FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP" (FMCPG)
FOR ALL "MEDICAL MARIJUANA DOCTORS" AND "MMTC DIRECTORS ONLY " TOPICS TO BE DISCUSSED THIS YEAR LEGISLATIVE PRIORITIES FOR TALLAHASSEE
UPDATES ON RFE REQUESTS
REPORTING OF BAD PLAYERS PROTECTING YOUR MEDICAL CANNABIS PRACTICE Becoming a Chapter of the Society of Cannabis Clinicians
QUESTIONS FROM PHYSICIANS HOW TO BEST ANSWER YOUR PATIENT QUESTIONS |
MEDICAL CANNABIS PHYSICIAN
PROMOTION PACKAGE BY CANNABIS NEWS FLORIDA ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).
E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.
The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK
RELATING TO THE BUSINESS OF MMTC'S IN FLORIDA Click on Company Logo to be Transferred to Web Site |
TRULIEVE EMPLOYEE TRAINING PROGRAM EARNS MULTIPLE GOLD AWARDS FOR EXCELLENCE
Leading cannabis multi-state operator recognized for innovative, best in class human capital management (“HCM”) strategy via implementation of its TruU-GROW Employee Training Program
Sept. 12, 2023 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced itshttps://cannabisnewsflorida.com/cannabis-stat/trulieve-employee-training-program-earns-multiple-gold-awards-for-excellence/TruU-GROW cultivation training program has received six Gold awards for excellence in the 2023 Brandon Hall Group HCM Excellence Awards™. The awards recognize best practices for initiatives in Learning and Development, Talent Management, Leadership Development, Talent Acquisition, Human Resources, Sales Performance, Diversity, Equity & Inclusion, and the Future of Work. Prior gold medal award winners include leading multinational companies such as Merck & Co., Kraft Heinz, IBM, Chevron, and Deloitte.
“Trulieve’s commitment to quality starts with ensuring every member of our team has the knowledge and resources needed to be great at their job,” said Trulieve’s Chief Production Officer Kyle Landrum. “The TruU-GROW training program is something we worked hard to design and implement to support our newest Trulievers, so to compete head-to-head against some of the largest companies in the world and take gold is something everyone here is extremely proud of.”
READ MORE |
GOLDLEAF BRINGS ITS UNPARALLELED LUXURY AT A VALUE MODEL TO FLORIDA CANNABIS, FEATURING LARGE SCALE RETAIL FOOTPRINT IN SEBRING AND WHITE GLOVE DELIVERY SERVICE
September 11, 2023 – GOLDLDEAF’s mission is to be the leading choice of Florida cannabis patients by providing the highest quality cannabis flower, oils, and edibles in the most beautiful retail environments (stores and white glove delivery) supported by extraordinary customer service. Goldleaf is focused on a unique positioning within the ever-growing cannabis market providing premium and luxury products and service at a value. GOLDLEAF’s team of growers are steeped in knowledge, with decades of collective experience. Using sustainable, organic techniques that were honed on the west coast, they carefully tend to their cannabis plants through each step of the process; GOLDLEAF is currently the only cultivator growing organically in Florida. The founders of GOLDLEAF are respected industry experts who came together to create something the cannabis market has never seen with the GOLDLEAF Model that you can experience at their first retail store in Sebring, or through White Glove delivery, currently offered across 15 central Florida counties and soon coming South Florida.
“We are excited to offer our patients a luxury experience while distributing the highest quality medical cannabis for the most affordable price in an ethical way. Our team is more than happy to deliver orders meeting our minimum requirement from our grow facility straight to your doorstep for no extra charge. We currently service 12 counties around central Florida with South Florida coming soon!” – Co Founder, Mark Seid
READ MORE |
ROSEMARY MAZANET, M.D., PHD. JOINS COLUMBIA CARE’S BOARD OF DIRECTORS
September 11, 2023– Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced the transition of Rosemary Mazanet, M.D., PhD., from Chief Scientific Officer, a role she has held since 2017, to a member of the Company’s Board of Directors, effective immediately.
Dr. Mazanet began advising Columbia Care in 2013 and then joined its Scientific Advisory Board as its Chair in 2015. Since 2013, she has played an integral role of developing groundbreaking form factors specifically for palliative care, such as pressed tablets. She also oversaw the creation of the seminal cannabis observational database that has provided analysis used in peer-reviewed journals, such as JAMA and the Journal of Palliative Medicine and by many of the nation’s leading academic and medical institutions such as National Institutes of Health, Columbia University, New York University, Mount Sinai, University of Southern California, and RAND Corporation. This database has also been used by policymakers at the federal and state level contributing to the development of cannabis policies that have advanced the industry. Following review and consideration, Dr. Mazanet was recommended for appointment by the Company’s Nominating and Governance Committee given her ability to contribute and add value to the Board based of her extensive medical, scientific, Company, industry, and public company experience.
READ MORE |
CURALEAF EXPANDS BRAND PORTFOLIO WITH LAUNCH OF ZERO PROOF ™ CANNABIS-INFUSED DRINKABLES
Zero Proof’s inaugural product offering, Squeeze, delivers fast-acting line of THC beverage enhancers in a sessionable and easy-to-use format
NEW YORK, Sept. 5, 2023 — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced the launch of Zero Proof, a new brand of THC drinkables in fast-acting, sessionable and easy-to-use formats. The brand’s inaugural product offering, Squeeze, is now available at all Curaleaf locations in Illinois and will be followed by additional SKUs in the coming months.
Zero Proof Squeeze follows Select’s popular THC-infused beverage enhancer, Select Squeeze, originally launched in March 2021. While similar in functionality and effect, Zero Proof Squeeze has been reformulated with natural sweetener to provide a significantly lighter taste and balanced flavor profile for enhanced mixability. The beverage complement offers a uniquely controllable and customizable experience with an easy-to-pour dispenser and compact design delivering 2.5mg THC per dose for discreet enjoyment on the go.
READ MORE |
NEW NAME
HOUSE OF PLATINUM CANNABIS |
CRESCO LABS OPENS 33RD FLORIDA SUNNYSIDE IN JACKSONVILLE, 70TH STORE NATIONWIDE
September 12, 2023 – — Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the opening of a second Sunnyside in Jacksonville, Florida. Located at 2725 College St., the new store joins its sister location in Jacksonville Beach in providing patients with greater access to best-in-class cannabis products from the Company’s branded portfolio. Today’s opening brings Cresco Labs’ store count to 33 dispensaries in Florida and 70 locations nationally.
READ MORE |
CRESCO LABS LAUNCHES FIRST-EVER CANNABIS ADVERTISEMENTS ON SPOTIFY, THE WORLD’S MOST POPULAR AUDIO STREAMING SUBSCRIPTION SERVICE
September 7 2023 – Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it is the first cannabis company to launch cannabis advertisements on Spotify, the world’s most popular audio streaming subscription service with more than 551 million users and 220 million subscribers.
Cresco Labs is the first cannabis company to launch cannabis advertising on Spotify. Pictured is an ad for the company’s national retail brand, Sunnyside.
READ MORE |
OVATION SCIENCE SIGNS LICENSE AGREEMENT WITH PLANET 13 FOR ITS TOPICAL / TRANSDERMAL CANNABIS PRODUCTS FOR NEVADA
VANCOUVER, BC and LAS VEGAS , September 11, 2023 – (CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. (“Ovation” or the “Company”), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare ® , today announced the signing of an exclusive licensing agreement with Planet 13 Holdings, Inc. (CSE: PLTH) (OTCQX: PLNHF) (“Planet 13”) , a leading vertically-integrated multi-state cannabis company, for the rights to Ovation’s topical / transdermal formulations for the state of Nevada .
Under the terms of the agreement, Planet 13 will have the exclusive manufacturing, sales and marketing rights for Ovation’s topical / transdermal products for Nevada . Ovation will receive royalties based on wholesale sales. Planet 13 owns and operates the world’s largest cannabis dispensary that has become a must-see destination for cannabis connoisseurs and tourists from around the world. Planet 13’s 112,000 square foot SuperStore and entertainment complex is located just off The Strip in Las Vegas . Planet 13 accounts for just under 9-percent of cannabis dispensary revenue for the entire state of Nevada .
READ MORE
|
NATIONAL AND INTERNATIONAL NEWS |
RAMM PHARMA CORP. ANNOUNCES CORPORATE UPDATE
TORONTO, Sept. 12, 2023 — On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the “Units”) of the Company at a price of $0.05 per Unit for total gross proceeds of up to $1,000,000 (the “Offering”). Each Unit would have been comprised of one common share in the capital of the Company (each, a “Common Share”), and one Common Share purchase warrant (each a “Warrant”), with each Warrant entitling the holder thereof to acquire one Common Share at a price of $0.05 for a period of 36 months following the closing date of the Offering. The proceeds from the Offering were expected to be used for working capital and general corporate purposes. The Offering was expected to close on or about September 26, 2023.
Ramm also announced its intention to commence a normal course issuer bid (the “NCIB”), under which it could have purchased up to 5% of the current number of issued and outstanding Common Shares. The NCIB would have commenced on or about September 5, 2023 and expired on the 12-month anniversary of the effective date of the NCIB.
READ MORE |
CANOPY GROWTH GERMANY GMBH ANNOUNCES BRAND CHANGE FROM SPECTRUM THERAPEUTICS TO CANOPY MEDICAL
SMITHS FALLS, ON, September 6, 2023– Canopy Growth Germany GmbH, a leading global provider of medical cannabis products and services, is pleased to announce that the Company is changing from Spectrum Therapeutics to Canopy Medical in the German market.
The decision to change the brand from Spectrum Therapeutics to Canopy Medical will align the Company’s medical business with the corporate Canopy Growth brand. This alignment further reinforces Canopy Growth’s commitment to long term growth within the German medical cannabis market and unwaivering commitment to German medical cannabis patients.
READ MORE |
OPTIMI HEALTH GRANTED AMENDMENT TO DEALER’S LICENCE BY HEALTH CANADA TO SUPPLY SPECIAL ACCESS PROGRAM
VANCOUVER, British Columbia, Sept. 07, 2023 — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly announced today that Health Canada has approved an amendment to the Company’s Dealer’s Licence. The amendment empowers Optimi to embark on the formal supply journey for Canada’s Special Access Program (SAP), operating within the provisions of the Controlled Drugs and Substances Act and its Regulations.
Under rigorous licensing regulations, Canadian entities engaged in the cultivation and formulation of psychedelic substances and who wish to supply Canada’s Special Access Program must secure approval from Health Canada’s Office of Controlled Substances Division. Optimi has successfully navigated this regulatory landscape, surmounting the initial hurdle required to supply MDMA and Psilocybin Drug Candidates produced under the Company’s Licence.
READ MORE |
TILRAY EXPANDS MARKET LEADING CANNABIS PORTFOLIO WITH LAUNCH OF NEW REDECAN PRODUCTS ACROSS CANADA
BEST-SELLING REDECAN BRAND GETS A BOOST WITH NEW LIMITED-EDITION CANNABIS FLOWER GENETICS AND PRODUCT LINEUP
TORONTO, Sept. 07, 2023 — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced the expansion of its market leading product portfolio with the launch of new flower genetics by best-selling cannabis lifestyle brand, Redecan. Redecan introduces a limited-edition series of exclusive whole flower cannabis genetics including; King Sherb and Animal RNTZ, two high-quality Indica strains meticulously cultivated by master growers. These new cannabis strains join the brand’s award-winning product portfolio, including consumer favorites like Wappa, Cold Creek Kush and Glueberry OG.
READ MORE |
AVEXTRA SIGNS DISTRIBUTION AGREEMENTS WITH PHARMACEUTICAL PARTNERS AND COMMENCES EXPORTS OF CANNABIS-BASED MEDICINES TO SWITZERLAND AND AUSTRIA
Avextra has signed distribution agreements with two pharmaceutical distribution partners in Switzerland and one partner in Austria
Avextra begins exports of standardized cannabis-based medicines from its EU-GMP German facility to its distribution partners in Switzerland and Austria
The Company continues to execute on its medical cannabis focused strategy, bringing highest quality cannabis-based medicines manufactured in Germany into core European markets
BENSHEIM, Germany, Sept. 07, 2023 — Avextra AG (“Avextra” or the “Company”), a leading vertically-integrated manufacturer of cannabis-based medicines located in Germany, is pleased to announce the signing of three long-term supply and distribution agreements. Avextra has signed distribution agreements with two leading Swiss pharmaceutical partners and one Austrian pharmaceutical distribution partner. Under the terms of the agreements, Avextra will supply its purified API Dronabinol as well as standardized cannabis extracts manufactured in its GMP facility in Germany to both Switzerland and Austria. With the necessary import permits and licenses in place, Avextra is currently executing the first export of its cannabis-based medicines into both markets, marking an important milestone in the company’s European growth strategy.
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS OVER 844,000 AND 589 DISPENSING LOCATIONS
|
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
SEPTEMBER 8, 2023 Report
BY THE NUMBERS Qualified Patients: (Active ID Card):
SEPT 8 2023- 844,148 SEPT 1 2023 - 842,512 AUG 25 2023- 841,580
AUG 18 2023- 840,041 AUG 11 2023- 838,470 Patients Last Week: 1,636
Qualified Ordering Physicians: 2,640
New Doctors Last Week: 7 Reporting Period: SEPT 1 TO SEPT 7 2023 Amount of Medical Marijuana Dispensed - (mgs THC) 321,045,534
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 3,046,579
Amount of Marijuana in a From for Smoking (oz) 107,364.370 Approved Dispensing Locations: 587 ADD LAST WEEK - 2
JUNGLE BOYS - BONITA SPRINGS SUNNYSIDE - JACKSONVILLE |
UPCOMING MEETING AND CONFERENCES |
IT'S TIME TO SHOW THE HEALTHCARE COMMUNITY HOW YOU HELP THEIR PATIENTS
PARTICIPATE IN SFHHA ANNUAL GOLF TOURNAMENT |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|